umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Review of health economic models for antibiotics
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin. Parexel International, Stockholm, Sweden.
Vise andre og tillknytning
2016 (engelsk)Inngår i: ISPOR 19TH ANNUAL EUROPEAN CONGRESS RESEARCH ABSTRACTS, ELSEVIER SCIENCE INC , 2016, Vol. 19, nr 7, s. A373-A373Konferansepaper, Poster (with or without abstract) (Fagfellevurdert)
Abstract [en]

Objectives: Critically appraise published health economic models evaluating treatments of bacteria resistant to antibiotics, focusing on methicillin-resistant Staphylococcus aureus (MRSA) and extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.

Methods: A structured literature review was conducted in Embase, identifying relevant publications by combining search facets for MRSA or ESBL, economic models, and antibiotics, excluding publications including the terms “animal” or “farm”. All search facets were search in the abstract and title, resulting in 40 publications. Two reviewers, blinded to the other’s initial evaluation, evaluated each of the titles and abstracts and found that 25 were relevant for a full review.

Results: The absolute majority of the identified studies presented cost-effectiveness models with a decision-analytic approach and a time horizon ranging from two to four weeks. The site of infection studied was dominated by nosocomial pneumonia as well as skin and soft tissue infections caused by MRSA. Only one model concerned gram-negative pathogens. No model was identified studying ESBL as the cause of infection. The most common antibiotic agents modelled were linezolid, vancomycin, daptomycin or their combination with a median of two treatment lines modelled. One model studies the cost-effectiveness of carbapenems. Sources used for informing antibiotic efficacy data were primarily published literature, clinical trials or clinical expert opinion. The most common outcome measures modelled were direct medical costs and resource utilization as well as efficacy measured by treatment success or antibacterial usage estimates. Four models (16%) included quality-adjusted life years (QALYs) as outcome measure.

Conclusions: The cost-effectiveness of linezolid and vancomycin for treatment of MRSA has been well-studied in various types of infections. There is a need for further cost-effectiveness and cost-benefit studies on antibiotic failure in more than two treatment lines, especially in carbapenem treatment of infections caused by ESBL, as these pose a significant resistance threat today.

sted, utgiver, år, opplag, sider
ELSEVIER SCIENCE INC , 2016. Vol. 19, nr 7, s. A373-A373
Serie
Value in Health, ISSN 1098-3015, E-ISSN 1524-4733
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-134292DOI: 10.1016/j.jval.2016.09.157ISI: 000396606300142OAI: oai:DiVA.org:umu-134292DiVA, id: diva2:1094251
Konferanse
ISPOR 19th Annual European Congress, 29 October - 2 November 2016, Austria Center Vienna, Vienna, Austria
Merknad

Meeting abstract PRM91

Tilgjengelig fra: 2017-05-09 Laget: 2017-05-09 Sist oppdatert: 2018-06-09bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekst

Personposter BETA

Geale, Kirk

Søk i DiVA

Av forfatter/redaktør
Geale, Kirk
Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 55 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf